These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38562737)

  • 1. Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization.
    Pavlyha M; Hunter M; Nowygrod R; Patel V; Morrissey N; Bajakian D; Li Y; Reyes-Soffer G
    medRxiv; 2024 Mar; ():. PubMed ID: 38562737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization.
    Pavlyha M; Hunter M; Nowygrod R; Patel V; Morrissey N; Bajakian D; Li Y; Reyes-Soffer G
    JVS Vasc Sci; 2024; 5():100211. PubMed ID: 39101011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort.
    Matveyenko A; Matienzo N; Ginsberg H; Nandakumar R; Seid H; Ramakrishnan R; Holleran S; Thomas T; Reyes-Soffer G
    J Lipid Res; 2023 Mar; 64(3):100336. PubMed ID: 36706955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
    Tsimikas S; Clopton P; Brilakis ES; Marcovina SM; Khera A; Miller ER; de Lemos JA; Witztum JL
    Circulation; 2009 Apr; 119(13):1711-9. PubMed ID: 19307470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study.
    Cicero AFG; Fogacci F; Derosa G; D'Angelo A; Ventura F; Rizzoli E; D'Addato S; Borghi C; On Behalf Of The Brisighella Heart Study Group
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
    Chan DC; Watts GF; Coll B; Wasserman SM; Marcovina SM; Barrett PHR
    J Am Heart Assoc; 2019 Apr; 8(7):e011781. PubMed ID: 30897995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.
    Blanchard V; Chemello K; Hollstein T; Hong-Fong CC; Schumann F; Grenkowitz T; Nativel B; Coassin S; Croyal M; Kassner U; Lamina C; Steinhagen-Thiessen E; Lambert G
    Cardiovasc Res; 2022 Jul; 118(9):2103-2111. PubMed ID: 34314498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant differentiation in the apolipoprotein(a)/lipoprotein(a) trait between chimpanzees from Western and Central Africa.
    Noureen A; Ronke C; Khalifa M; Halbwax M; Fischer A; André C; Atencia R; Garriga R; Mugisha L; Ceglarek U; Thiery J; Utermann G; Schmidt K
    Am J Primatol; 2017 Sep; 79(9):. PubMed ID: 28671714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
    Hopewell JC; Seedorf U; Farrall M; Parish S; Kyriakou T; Goel A; Hamsten A; Collins R; Watkins H; Clarke R;
    J Intern Med; 2014 Sep; 276(3):260-8. PubMed ID: 24372611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans.
    Marcovina SM; Albers JJ; Wijsman E; Zhang Z; Chapman NH; Kennedy H
    J Lipid Res; 1996 Dec; 37(12):2569-85. PubMed ID: 9017509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
    Saku K; Zhang B; Liu R; Shirai K; Arakawa K
    Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia.
    Bowden JF; Pritchard PH; Hill JS; Frohlich JJ
    Arterioscler Thromb; 1994 Oct; 14(10):1561-8. PubMed ID: 7918305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect.
    Gaw A; Brown EA; Ford I
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1870-6. PubMed ID: 9848878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.
    Singh N; Ding L; Devera J; Magee GA; Garg PK
    JAMA Netw Open; 2021 Dec; 4(12):e2136014. PubMed ID: 34860245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic opioid use in patients with peripheral arterial disease undergoing revascularization.
    Velazquez-Ramirez G; Krebs J; Stafford JM; Ur R; Craven TE; Stutsrim AE; Goldman MP; Hurie JB; Edwards MS
    J Vasc Surg; 2022 Jan; 75(1):186-194. PubMed ID: 34478808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.